Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | QPCT | Q16769 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.34 |
| ▸ | HTR3B | O95264 | 1/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.34 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21258901 | 0.85 | CDK2 (0.42) | HTTSMN1; SMN2LMNAEPHX1ALDH1A1 | |
| SCHEMBL24991254 | 0.81 | HTT (0.47) | NPC1RAB9AHTTSMN1; SMN2LMNA | |
| SCHEMBL254189 | 0.75 | EPHX1 (0.46) | NPC1RAB9AEPHX1MAPK1KDM4E | |
| SCHEMBL21258650 | 0.74 | KEAP1 (0.45) | EPHX1 | |
| SCHEMBL21258649 | 0.74 | EPHX1 (0.34) | HTTEPHX1MAPTMAPK1ALDH1A1 | |
| SCHEMBL17133246 | 0.72 | LMNA (0.65) | NPC1RAB9AHTTSMN1; SMN2LMNA | |
| SCHEMBL17282531 | 0.72 | QPCT (0.33) | NPC1RAB9AQPCTHTTSMN1; SMN2 | |
| SCHEMBL2755807 | 0.72 | ALDH1A1 (0.39) | SMN1; SMN2MAPTMAPK1KDM4EALDH1A1 | |
| SCHEMBL28413006 | 0.72 | EPHX1 (0.36) | NPC1RAB9ALMNAEPHX1MAPK1 | |
| SCHEMBL17030472 | 0.71 | KEAP1 (0.54) | RAB9AQPCTSMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092212-A1 | SELECTIVE ETCH INHIBITOR COMPOUNDS AND RELATED METHODS | ENTEGRIS INC (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092212-A1 | SELECTIVE ETCH INHIBITOR COMPOUNDS AND RELATED METHODS | APOL1, ATXN2L, SRSF9 | NPC1 1493/4885RAB9A 1415/4885QPCT 4535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.